Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assurant (AIZ) Cash & Equivalents (2016 - 2026)

Assurant has reported Cash & Equivalents over the past 17 years, most recently at $1.8 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 1.46% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, up 1.46%, while the annual FY2025 figure was $1.8 billion, 1.46% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.8 billion at Assurant, up from $1.7 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.7 billion in Q2 2021 and troughed at $1.2 billion in Q2 2022.
  • A 5-year average of $1.7 billion and a median of $1.6 billion in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 30.27% in 2021 and later tumbled 56.96% in 2022.
  • Year by year, Cash & Equivalents stood at $2.0 billion in 2021, then decreased by 24.7% to $1.5 billion in 2022, then grew by 5.9% to $1.6 billion in 2023, then increased by 11.08% to $1.8 billion in 2024, then rose by 1.46% to $1.8 billion in 2025.
  • Business Quant data shows Cash & Equivalents for AIZ at $1.8 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.5 billion in Q2 2025.